We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLS.L Regulatory News (SLS)

  • There is currently no data for SLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Standard Life UK Smaller Co

25 Oct 2019 11:31

RNS Number : 1870R
Standard Life UK Small.Co's Tst PLC
25 October 2019
 

 

London, UK, 25 October 2019

Edison issues review on Standard Life UK Smaller Companies (SLS)

Standard Life UK Smaller Companies (SLS) has a long-term record of significant outperformance versus its benchmark. Manager Harry Nimmo says that his disciplined investment process, which focuses on quality, growth and momentum, also provides an element of resilience in periods of market weakness. He is encouraged by the trust's growing level of income, which is allowing SLS to employ a progressive dividend policy, and argues that over the long term, investors have been well served by an allocation to smaller UK companies as they have outperformed the broader UK market. The trust's board actively employs a discount control mechanism, and has recently been repurchasing shares as SLS's discount has bumped up against its 8% target maximum.

 

The board actively manages SLS's discount, aiming for a maximum 8% in normal market conditions; the primary method is via share repurchases. The trust's shares are currently trading at a 5.7% discount to cum-income NAV, which compares with the 5.0% to 7.6% range of average discounts over the last one, three, five and 10 years. SLS has a long-term history of dividend growth, compounding at an annual rate of 17.0% over the last decade; it currently yields 1.5%.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRALLFFIIDLEFIA
Date   Source Headline
27th Oct 202112:23 pmRNSNet Asset Value(s)
27th Oct 202111:45 amRNSChange of Name
26th Oct 20215:15 pmRNSTransaction in Own Shares
26th Oct 202111:26 amRNSNet Asset Value(s)
25th Oct 20215:20 pmRNSTransaction in Own Shares
25th Oct 20213:02 pmRNSGearing Disclosure
25th Oct 202112:43 pmRNSNet Asset Value(s)
22nd Oct 20215:23 pmRNSTransaction in Own Shares
22nd Oct 202112:33 pmRNSNet Asset Value(s)
21st Oct 20212:35 pmRNSResult of AGM
21st Oct 202112:05 pmRNSNet Asset Value(s)
20th Oct 20215:10 pmRNSTransaction in Own Shares
20th Oct 20211:10 pmRNSNet Asset Value(s)
19th Oct 20215:21 pmRNSTransaction in Own Shares
19th Oct 202112:28 pmRNSNet Asset Value(s)
18th Oct 20215:06 pmRNSTransaction in Own Shares
18th Oct 202112:31 pmRNSGearing disclosure
18th Oct 202111:48 amRNSNet Asset Value(s)
15th Oct 20215:09 pmRNSTransaction in Own Shares
15th Oct 202111:51 amRNSNet Asset Value(s)
14th Oct 20215:28 pmRNSTransaction in Own Shares
14th Oct 202112:03 pmRNSPortfolio disclosure
14th Oct 202111:48 amRNSNet Asset Value(s)
13th Oct 20215:00 pmRNSTransaction in Own Shares
13th Oct 202112:23 pmRNSNet Asset Value(s)
12th Oct 20215:59 pmRNSTransaction in Own Shares
12th Oct 202112:43 pmRNSNet Asset Value(s)
11th Oct 202112:23 pmRNSGearing disclosure
11th Oct 202111:22 amRNSNet Asset Value(s)
8th Oct 202112:47 pmRNSNet Asset Value(s)
8th Oct 20217:00 amRNSEdison review on Standard Life UK Smaller Co Tst
7th Oct 20214:48 pmRNSTransaction in Own Shares
7th Oct 202112:29 pmRNSNet Asset Value(s)
6th Oct 20215:18 pmRNSTransaction in Own Shares
6th Oct 20213:10 pmRNSMonth End Net Asset Value(s)
6th Oct 202111:03 amRNSNet Asset Value(s)
5th Oct 20215:21 pmRNSTransaction in Own Shares
5th Oct 202111:30 amRNSNet Asset Value(s)
4th Oct 20215:31 pmRNSTransaction in Own Shares
4th Oct 20214:53 pmRNSQuarterly disclosure
4th Oct 20213:02 pmRNSGearing disclosure
4th Oct 202112:31 pmRNSNet Asset Value(s)
1st Oct 202110:18 amRNSTotal Voting Rights
30th Sep 20215:18 pmRNSTransaction in Own Shares
30th Sep 20211:59 pmRNSNet Asset Value(s)
29th Sep 20215:25 pmRNSTransaction in Own Shares
29th Sep 202112:41 pmRNSNet Asset Value(s)
28th Sep 20215:11 pmRNSTransaction in Own Shares
28th Sep 202112:29 pmRNSNet Asset Value(s)
27th Sep 20215:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.